alexa Surface Derivatization Of Zirconium Phosphate Nanoplatelets: Potential Nanocarrier Of Doxorubicin Anticancer Drug
ISSN: 2150-3494

Chemical Sciences Journal
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

4th European Chemistry Congress
May 11-13, 2017 Barcelona, Spain

Julissa Gonzalez Villegas
University of Puerto, United States
Posters & Accepted Abstracts: Chem Sci J
DOI: 10.4172/2150-3494-C1-009
Abstract
Surface modification of doxorubicin anticancer drug (DOX) intercalated zirconium phosphate (ZrP) nanoparticles ([email protected]) is proposed to improve the potential of this drug delivery system for cancer therapy. The surface of [email protected] nanoparticles was modified with an amorphous layer of Zr(IV) followed by modification with monomethyl-polyethylene glycol-monophosphate (m-PEG-PO3) to increase the [email protected] biocompatibility. 31P{1H}MAS NMR data shows a new peak at -26 ppm corresponding to the PO4 3- groups coordinated with Zr(IV) on the surface. m-PEG-PO3/Zr(IV)[email protected] spectra shows no additional resonance centered at δ of -22.6 ppm generated by proton-phosphorous cross polarization indicating no partial PEG intercalation in the interlaminar space. Simulated body fluid (SBF) was used to determine the in vitro release of DOX from [email protected], Zr(IV)/DOX@ ZrP, and m-PEG-PO3/ Zr(IV)[email protected] MTS cell viability assay reveal that m-PEG-PO3/ Zr(IV)[email protected] exhibited a 20% increase in the toxicity comparing with free DOX when PC3 cells are exposed for 48 h. m-PEG-PO3 polymer coating of [email protected] nanoparticles promise to have a strong impact on the targeting, distribution and degradation of the nanoparticles under physiological environment that should result in a more efficient chemotherapy agent than free doxorubicin.
Biography

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords